S-1: SHF Holdings Faces Nasdaq Delisting Amid Financial Woes

SHF Holdings, Inc. is facing delisting from Nasdaq due to low stock price, while grappling with significant operating losses and substantial doubt about its ability to continue as a going concern.

Summary

• SHF Holdings, Inc. is filing an S-1 registration statement to allow selling stockholders to offer up to 115,705,691 shares of Class A Common Stock.
• The company's Common Stock is set to be delisted from Nasdaq on November 18, 2026, due to a persistent low closing bid price.
• SHF Holdings has identified material weaknesses in its internal controls over financial reporting, particularly concerning loan documentation and credit loss estimation.
• The company has incurred recurring operating losses and negative cash flows, raising substantial doubt about its ability to continue as a going concern.
• A proposed transaction with Opifex Media, Inc. is subject to numerous conditions and may result in substantial dilution to existing stockholders.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as highly negative due to the impending delisting from Nasdaq, significant ongoing operating losses, and substantial doubt about the company's ability to continue as a going concern.

Positives

• The Second Amended Commercial Alliance Agreement (CAA) with PCCU, effective October 1, 2025, increased SHF's share of loan program income to up to 65%, improving its revenue profile.
• The company has a proprietary compliance technology platform that has processed over $38.7 billion in cannabis-related deposit activity since 2015.
• The company has a decade of experience navigating regulatory requirements in cannabis banking and has passed numerous audits.
• The company has access to an Equity Line of Credit (ELOC) of up to $150 million, potentially expandable to $500 million, providing contingent liquidity.

Negatives

• The company's Common Stock is scheduled for delisting from Nasdaq on November 18, 2026, due to a closing bid price below $0.10 for ten consecutive trading days.
• There is substantial doubt about the company's ability to continue as a going concern, with recurring operating losses and negative cash flows.
• The company has identified material weaknesses in internal controls over financial reporting related to loan documentation and credit loss estimation.
• The proposed transaction with Opifex Media, Inc. is non-binding and faces significant conditions, with no assurance of completion.
• The company faces significant dilution risks from the conversion of Series B Preferred Stock and exercise of Series B Warrants, as well as from draws under the ELOC.

Risks

• Impending delisting from Nasdaq and potential trading on over-the-counter markets, which could reduce liquidity and market price.
• Substantial doubt about the company's ability to continue as a going concern due to recurring operating losses and negative cash flows.
• Material weaknesses in internal controls over financial reporting related to loan documentation and credit loss estimation.
• The proposed transaction with Opifex may not be completed, and if it is, it would substantially dilute existing stockholders and change the business.
• The company's significant concentration of revenue from a single customer, PCCU, poses a material risk if the relationship deteriorates or terminates.
• The company's indemnification obligations under the Second Amended CAA are unlimited and could exceed available cash.
• The cannabis industry's federal illegality continues to pose regulatory and legal risks.
• Potential for adverse rulings in ongoing litigation, particularly the Abaca litigation, which could result in significant financial judgments.

Future Outlook

The company's future outlook is highly uncertain, marked by an impending Nasdaq delisting, ongoing operating losses, and substantial doubt about its ability to continue as a going concern. While the Second Amended CAA aims to improve revenue, the company's ability to execute its strategic plans, including the potential Opifex transaction, and regain Nasdaq compliance remains critical.

Management Comments

• Management has developed and implemented a series of measures intended to preserve liquidity and support the Company's ability to meet its obligations during the look-forward period.
• Management believes that its platform, established relationships with financial institution customers, and proprietary compliance infrastructure position it to benefit from an industry recovery.
• Management believes that a rescheduling of cannabis from Schedule I to Schedule III would decrease tax burdens for cannabis operators and improve the financial stability of CRBs.

Industry Context

StockSavvy.ai notes that SHF Holdings operates in the challenging intersection of the cannabis industry, which faces federal illegality, and the highly regulated financial services sector. The company's business model is directly impacted by evolving state and federal cannabis regulations, including potential rescheduling and banking reform legislation like the SAFER Banking Act.

Comparison to Industry Standards

• The company's revenue concentration with PCCU (93% in Q3 2026) is significantly higher than typical for diversified financial service providers.
• The company's struggle to maintain Nasdaq listing standards (minimum bid price, market value of listed securities) highlights the financial pressures faced by many smaller companies in niche or emerging industries.
• The company's reliance on a single primary financial institution partner (PCCU) is a notable deviation from industry best practices, which emphasize diversification of banking relationships to mitigate counterparty risk.

Management Changes

Legal Proceedings

• The company is involved in litigation concerning the acquisition of Abaca, with an adverse ruling potentially costing between $0 and $7.8 million.
• The company received a delisting determination from Nasdaq due to a low closing bid price, with trading suspension set for November 18, 2026.
• The company is subject to Nasdaq Listing Rule 5810(c)(3)(A)(iii) due to a closing bid price of $0.10 or less for ten consecutive trading days.

Related Party Transactions

• The company's relationship with Partner Colorado Credit Union (PCCU) is governed by the Second Amended Commercial Alliance Agreement, which significantly impacts revenue and indemnification obligations.
• PCCU sold all of its Series B Preferred Stock on October 21, 2026, and is no longer considered a related party, though it remains a significant customer.
• Certain officers and directors participated in the Series B Preferred Stock offering, with their participation approved by stockholders.

Stakeholder Impact

• Shareholders face significant dilution risk from the conversion of Series B Preferred Stock and exercise of Series B Warrants, as well as potential draws under the ELOC.
• The impending delisting from Nasdaq will likely reduce the liquidity and market price of the Common Stock, making it harder for investors to trade shares.
• Employees may be impacted by the company's financial distress and potential restructuring or operational curtailment.
• Creditors and noteholders face uncertainty regarding the company's ability to continue as a going concern and meet its financial obligations.

Next Steps

• The company must regain compliance with Nasdaq's minimum bid price requirement by April 19, 2027, to avoid delisting.
• The company is evaluating options to appeal Nasdaq's delisting determination.
• The company is pursuing a potential transaction with Opifex Media, Inc., subject to numerous conditions.
• The company must file a registration statement related to Series B securities to avoid potential Triggering Events.
• The company is working to remediate material weaknesses in internal controls over financial reporting.

Key Dates

Recommendation

The company is facing imminent delisting from Nasdaq, has substantial doubt about its ability to continue as a going concern due to ongoing losses, and has identified material weaknesses in internal controls. The proposed transaction with Opifex is highly uncertain and may lead to significant dilution. These factors present an extremely high risk profile for investors.

Keywords

Cannabis Banking, Financial Services, Regulatory Compliance, CRB Lending, Fintech, SEC Filing, Form S-1, SHF Holdings